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Abstract
Over 30,000 people receive a solid organ transplant each year, with 5-30% developing posttransplant diabetes mellitus (PTDM) (United Networking for Organ Sharing, 2015). At a
Midwestern transplantation center, over 22% of patients with a history of diabetes were not
consulted to endocrinology after kidney and liver transplantation. With poor glycemic control,
there is an increased risk of developing PTDM leading to poor outcomes. Utilizing the
Donabedian model and the Six Sigma’s Define, Measure, Analyze, Improve, and Control
(DMAIC) as guides for implementation, the purpose of this project was to address the process
measures of increasing appropriate consultations for evaluation and treatment of PTDM patients
that would lead to an important quality measure of improved glycemic control for this
population. The project involved the implementation of a clinical pathway to address this quality
measure. Even though there was not a statistically significant change in number of consultations,
there was a clinical meaningful difference because the patients who were consulted after
pathway implementation received the benefit of management by endocrinology specialists to
improve glycemic control post transplantation. Limitations of the project leading to the reported
results include that the sample size was less than 30 and the period of evaluation was only one
month. The recommendation is for transplant and endocrinology teams to continue to work
together to develop clinical pathways to appropriately consult endocrinology teams that is
consistent with the standardized care of other organ transplants. Though this is a small piece to a
larger problem, the use of standardized pathways will potentially improve care leading to
improved glycemic control in the kidney and liver transplant population. Early consultation
immediately after surgery will potentially improve the transitions of care from inpatient to
outpatient setting for this patient population.
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Executive Summary
Close to 30,000 people receive a solid organ transplant each year in the United States, 5% 30% develop post-transplant diabetes mellitus (PTDM) (United Networking for Organ Sharing,
2015). This wide range of incidence is likely due to the inconsistent definition of PTDM.
PTDM, formerly called new onset diabetes after transplantation (NODAT), has been recognized
as a complication after transplantation since the early 1960’s (Stevens, Patel, & Jardine, 2012).
In 2014, the International Consensus Guidelines changed the terminology from NODAT to
PTDM to address the condition occurring in the post transplantation setting regardless if it was
present but undetected prior to transplantation (Sharif et al., 2014). The condition can be
diagnosed only 30-45 days after transplantation. These guidelines also recommended the term
“pre-diabetes mellitus” to be used for patients with post-transplant hyperglycemia who have not
surpassed the threshold values for the diagnosis of PTDM (Sharif et al., 2014).
There are several risk factors for PTDM that include age, obesity, African-American race and
Hispanic ethnicity, family history, impaired glucose tolerance, Hepatitis C virus,
immunosuppression therapy, underlying kidney disease, HLA mismatches, and induction therapy
(Wilkinson et al., 2005). Patients who are diagnosed with PTDM have close to an 80% increase
in mortality from any cause and over a 45% increase in mortality from cardiovascular disease
(Cosio, Hickson, Griffin, Stegall, & Kudva, 2008). This condition is also linked to a 24%
increase risk of graft failure along with acute rejection (Cole, Johnston, Rose, & Gill, 2008).
A midwestern transplantation center, a division of a large academic medical center, has
ranked in the top 20% nationally in patient outcomes as well as the number of transplants
performed. This center serves as the largest and most successful transplantation program in the
midwest (Hospital in Midwest, 2015). Despite the high quality that this center provides for their

QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT

7

patients, PTDM is still a concern, as with almost all transplant centers. Between November 1,
2014 and February 28, 2015, this center performed over 100 transplants. Over 20% of kidney
and liver transplant patients with a history of diabetes were not consulted by endocrinology for
proper glycemic control. With poor glycemic control (BG<70 mg/dL, BG>140 mg/dL), there is
an increased risk of these patients developing PTDM.
Currently there is no integration of diabetes management into the primary transplant team
decisions causing lack of glycemic control, lack of or delayed endocrinology consultation, and
lack of formal diabetes education after transplantation occurs. Heart and lung transplant patients
receive endocrinology consultation, whereas the kidney and liver transplant patients do not. The
lack of standardized care among these transplant patients has been confusing for nursing staff but
has also been part of the health care culture for over a decade.
Effective interventions for this population include identifying patients at risk, performing
early and repetitive screening, and aggressively treating patients with PTDM (Rakel & Karelis,
2011). Boerner, Shivaswamy, Goldner, and Larsen (2015) discuss how the collaboration with
multidisciplinary teams will result in improved glycemic control and decrease the risk of PTDM
in the post-transplant population. Early consultation with the endocrinology team is one example
of this phenomenon, which not only improves patient outcomes but eases the burden of the
primary transplant team (Boerner et al., 2015). Evidence suggests that with pathways in place to
guide appropriate consultation with endocrinology, treatment to control blood sugar is initiated
earlier.
The purpose of this project was to address the process measures of increasing appropriate
consultations for evaluation and treatment of PTDM patients that would lead to an important
quality measure of improved glycemic control for this population. This was addressed by
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answering the clinical question: Will appropriate consultations to the endocrinology service
occur in patients with abnormal glucose in the post-transplant period after initiation of a nurse
driven clinical pathway?
The conceptual frameworks of the Donabedian model and the DMAIC quality improvement
processes to guide this quality improvement project involved the implementation of a clinical
pathway to address this quality measure. Even though there was not a statistically significant
change in the number of consultations, there was a clinical meaningful difference because the
patients who were consulted after pathway implementation received the benefit of management
by endocrinology specialists to improve glycemic control post transplantation. Limitations of
the project leading to the reported results included that the sample size was less than 30 and the
period of evaluation was only one month. For project sustainability, it was recommended that a
longer evaluation period occur to assess for statistically significant improvement regarding the
number of consultations initiated with this pathway. With transplantation highly regulated, these
interventions will not only affect patient outcomes and improve patient safety; but could improve
the center’s approval status with Centers for Medicare and Medicaid Services (CMS) by
improving transplantation outcomes (Centers for Medicare & Medicaid Services, 2015).
Cost considerations for this project required human resources and time of the endocrinology
team working together to approve a clinical pathway for endocrinology consultation. Additional
resources involved the time necessary to train nursing staff on the pathway implementation as
well as the financial cost of sustainability, cost of in-services, and the use of conference rooms
for the in-services. Furthermore, the cost of time from stakeholders, managers, educators,
endocrine service, transplant team, and the Doctor of Nursing Practice (DNP) student to review,
approve, and implement the quality improvement project was taken into consideration. Even
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with these cost considerations, there is an estimated potential yearly cost savings as high as
$292,864.24 for kidney transplant patients and as high as $220,704.24 for liver transplant
patients if glycemic control could be improved. The recommendation is for transplant and
endocrinology teams to continue to work together to develop clinical pathways to appropriately
consult endocrinology teams that is consistent with the standardized care of other organ
transplants. Though this is a small piece to a larger problem, the use of standardized pathways
will potentially improve care leading to improved glycemic control in the kidney and liver
transplant population. Early consultation immediately after surgery will potentially improve the
transitions of care from inpatient to outpatient setting for this patient population.
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Quality Improvement Initiative in Transplant Diabetes Care: Needs Assessment and Protocol
Development
Of the 30,000 people receiving a solid organ transplant each year in the United States, 5% 30% develop post-transplant diabetes mellitus (PTDM) (United Networking for Organ Sharing,
2015). The wide range of incidence is likely due to the inconsistent definitions of PTDM.
PTDM, formerly called new onset diabetes after transplantation (NODAT), has been recognized
as a complication after transplantation since the early 1960’s (Stevens, Patel, & Jardine, 2012).
In 2014, the International Consensus Guidelines changed the terminology from NODAT to
PTDM to address the condition occurring in the post transplantation setting regardless if it was
present, but undetected prior to transplantation (Sharif et al., 2014).
PTDM is associated with increase cardiovascular morbidity, reduced graft function, and lower
survival rates among patients (Midtvedt et al., 2011). From an organizational standpoint, organ
transplantation is highly regulated. The Centers for Medicare and Medicaid Services (CMS) and
Organ Procurement and Transplant Network (OPTN), serve as regulating bodies for transplant
centers (Scientific Registry of Transplant Recipients, 2015). Patient outcomes do not affect
reimbursement to an organization, however poor patient outcomes do affect regulatory review,
particularly CMS certification (Centers for Medicare & Medicaid Services, 2015).
Problem Statement
Patients who are diagnosed with PTDM have close to an 80% increase in mortality from any
cause and over a 45% increase in mortality from cardiovascular disease (Cosio, Hickson, Griffin,
Stegall, & Kudva, 2008). This condition is also linked to a 24% increase risk of graft failure
along with acute rejection (Cole, Johnston, Rose, & Gill, 2008). At one transplant center, over
20% of kidney and liver transplant patients with a history of diabetes were not consulted by the
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endocrinology team for evaluation and treatment of abnormal glucose levels. Of these patients
not consulted, 51% of kidney transplant patients recorded having two or more readings of blood
glucose (BG) levels less than 60 mg/dL during their hospital stay. Whereas, 67% of liver
transplant patients not consulted recorded having two or more readings of blood glucose (BG)
levels greater than 200 mg/dL. With poor glycemic control (BG<70 mg/dL, BG>140 mg/dL),
there is an increased risk of these patients developing PTDM. Currently, PTDM accounts for
roughly over $21,000 per patient over two years when compared with those patients who did not
develop PTDM (Woodward et al., 2003). If this trend continues, health care costs will rise,
patient outcomes will decline, and transplant centers will struggle to maintain CMS certification.
Appropriate consultation to the endocrinology service for at risk patients is one treatment to
improve glycemic control. Looking at this small piece of the puzzle, the clinical question is:
Will appropriate consultations to the endocrinology service be initiated in patients with abnormal
glucose in the post-transplant period after initiation of a nurse driven clinical pathway?
Exploring the current literature of risk factors for PTDM as well as interventions to improve
glycemic control will assist in addressing this clinical question.
Evidence-Based Initiative
The 2014 International Consensus Guidelines by Sharif et al. (2014) classify PTDM as:


Symptoms of hyperglycemia (i.e., polyuria, polydipsia, polyphagia), plus random plasma
glucose ≥200 mg/dL (11.1 mmol/L) and/or



Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) on at least two occasions and/or



Two hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance
test (OGTT) and/or



Hemoglobin A1C (A1C) level ≥6.5%.
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The timeframe for diagnosis of PTDM is only 30-45 days after transplantation. These guidelines
also recommended the term “pre-diabetes mellitus” to be used for patients with post-transplant
hyperglycemia who have not surpassed the threshold values for the diagnosis of PTDM (Sharif et
al., 2014).
Several risk factors associated with PTDM have been identified in the literature. Common
risk factors among all solid organ transplantations are heredity, obesity, hepatitis C (HCV),
cytomegalovirus (CMV) virus, and tacrolimus use (Marchetti, 2005; Mirabella et al., 2005).
Specific risk factors for kidney transplantation include age, race/ethnicity, family history of
diabetes, immunosuppression therapy, induction therapy, and hyperglycemia before and/or after
transplantation. Of these risk factors, Cosio, Pesavento, Osei, Henry, & Ferguson (2001)
determined age over 45 in transplant recipients was the strongest and most consistent risk factor
for PTDM in kidney transplantation. Obesity, African American and Hispanic descent, and the
other common risk factors also contributed to PTDM in this population (Kasiske et al., 2003;
Friedman, Miskulin, Rosenberg, & Levey, 2003; Santos et al., 2012; Shah et al., 2006).
Basiliximab (Simulect) induction therapy has proven to be effective in reducing the rate of
acute rejections as well as limit the dosages of calcineurin inhibitors and steroids necessary in the
early post transplantation period (Vincenti et al., 2006). However, previous studies suggest an
increased incidence of PTDM in patients who received basiliximab (Aasebo et al., 2010; Bayes
et al., 2007).
Effective interventions for this population include identifying patients at risk, performing
early and repetitive screening, and aggressively treating patients with PTDM (Rakel & Karelis,
2011). Boerner, Shivaswamy, Goldner, and Larsen (2015) discuss how the collaboration with
multidisciplinary teams will result in improved glycemic control and decrease the risk of PTDM

QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT

13

in the post-transplant population. Early consultation with the endocrinology team is one example
of this phenomenon, which not only improves patient outcomes but eases the burden of the
primary transplant team (Boerner et al., 2015).
At the Medical University of South Carolina (MUSC), the endocrinology department
developed a Diabetes Management Service (DMS) that provides 24/7 concurrent care for the
management of hyperglycemia and diabetes-related consults to all adult inpatient units. This
organization found that DMS involvement tended to reduce graft failure rates from 20% to 6% in
renal transplant patients (Medical University of South Carolina, 2015). From these results, DMS
coordinated post-discharge follow up visits to reduce the readmission rates related to poor
glycemic control. Currently, at this study organization, all diabetic renal transplant patients are
seen by the endocrinology team weekly for the first four weeks post transplantation. This
appointment is on the same day as their transplant clinic follow up. MUSC also determined that
early consultation of DMS in patients with glycemic control issues resulted in significantly
shorter length of stay compared to other patients (Medical University of South Carolina, 2015).
Another organization studied the post-operative glycemic control in heart transplant patients.
In this retrospective study, the Glucose Management Service (GMS) implemented inpatient
insulin protocols to obtain glycemic control in patients with and without diabetes. The time
period from the time the insulin drip was initiated until it was discontinued was defined as the IV
insulin protocol time period. The transition protocol consisted of insulin glargine given daily.
As part of the protocol, patients were seen daily by a member of the GMS team to determine the
insulin response of each patient. Insulin was reduced daily as the reduction in postoperative
stress and steroid dosing decreased. Nurse practitioners could deviate from this protocol and
individualize care. The results indicated that with the use of these protocols, heart transplant
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patients reported postsurgical outcomes at 30 days with adequate control of blood glucose with
minimal hypoglycemia events. With the implementation of glycemic control protocols,
postsurgical outcomes improved (Wallia et al., 2014).
The same organization that initiated insulin protocols in heart transplant patients analyzed
glycemic control by the Glucose Management Service (GMS) and infection rates in liver
transplantation. The retrospective study evaluated 73 liver transplant recipients who were treated
with insulin infusions, before and after introduction of GMS. The purpose of the study was to
analyze patients who were followed by GMS compared to non-GMS management. The results
indicated that the number of days in the intensive care unit as well as the length of stay (LOS) in
the hospital was greater in the non-GMS group than the GMS group. Also infection rates in the
GMS group were lower than for the non-GMS group (Wallia et al., 2011). Based on these
outcome measures, within one year post liver transplantation, outcomes of patients followed by
the GMS was associated with improved glycemic control and decreased postoperative infections
(Wallia et al., 2011).
Since there is an inconsistent definition of PTDM, proper identification of patients at risk of
PTDM, and with utilization of the evidence from the current literature, interventions can be
implemented to improve glycemic control in a transplant center. Evidence suggests that with
pathways in place to guide appropriate consultation with endocrinology, treatment to control
blood sugar is initiated. With appropriate glycemic treatment, patient outcomes can be
improved.
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Conceptual Models
The Donabedian Model
Conceptual models serve as frameworks needed to explain the phenomenon and guide
interventions. The Donabedian model is a conceptual model that provides a framework for
examining health services and evaluating quality of health care (Donabedian, 1988). Avedis
Donabedian, a physician and health services researcher at the University of Michigan, first
developed the model in 1966. According to the model, there are three categories: structure,
process, and outcomes (See Appendix A). Structure describes the context of the setting in which
care is delivered. This can include material resources from the hospital building, staff, methods
of reimbursement, and equipment. The process denotes the transactions between patients and
providers including pathways and measures to deliver care. Finally, outcomes refer to the effects
on the health status of patients and populations in response to structure and process (Donabedian,
1988). This model was developed to be flexible enough for application in diverse healthcare
systems and among various levels within a delivery system. The model can be used to modify
structures and processes within a healthcare delivery system such as improving glycemic control
by developing protocols to guide early consultation with endocrinology. With improved
processes and structure established, this model draws connections to improve patient outcomes,
which are vital to this phenomenon. The Donabedian model will serve as a framework to guide
interventions in this proposal along with another methodology to implement process
improvements.
Six Sigma
Six sigma is a method that provides organizations tools to improve processes and increase
performance. The decrease in process variation and increase in performance improves outcomes,
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employee morale, and quality of services provided (Pande, Neuman, & Cavanagh, 2002). This
perspective is data and fact driven, utilizing qualitative and quantitative techniques to drive
process improvement (Pande, Neuman, & Cavanagh, 2002). Tools that illustrate this process can
be in the form of diagrams, control charts, processing mapping, and failure mode and effects
analysis (Pande, Neuman, & Cavanagh, 2002).
Process improvement strategies eliminate the root causes of performance problems in an
organization, which is an integral part of six sigma. DMAIC (define, measure, analyze, improve,
and control) is an acronym for the five phases used in six sigma methodology (Pande, Neuman,
& Cavanagh, 2002) (See Appendix B).
Each step in the DMAIC process is required to ensure the best possible result:


Define the problem, project boundaries, and process to be improved by performing an
organizational assessment (Pande, Neuman, & Cavanagh, 2002).



Measure the process performance through data collection from multiple sources (Pande,
Neuman, & Cavanagh, 2002).



Analyze the data collected and process map to determine root causes of poor performance
and identify gaps between current performance and goal performance (Pande, Neuman,
& Cavanagh, 2002).



Improve process performance by developing solutions addressed in the root causes
(Pande, Neuman, & Cavanagh, 2002).



Control the improved process and future process performance by implementing
continuous monitoring and incentives for quality improvement (Pande, Neuman, &
Cavanagh, 2002).
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The DMAIC approach is a conceptual framework that guides an organization through process
and quality improvements. An organization can employ this methodology to illustrate root
causes for poor glycemic control as well as improve the process measures to recognize and
intervene on the risk factors associated with PTDM. The organization has successfully used this
framework for quality improvement project work in the past and staff are familiar with this
process. This was the reason this framework was chosen to guide the project intervention.
Need and Feasibility Assessment of the Organization/Population
A midwestern transplantation center, a division of a large academic medical center, has been
providing solid organ transplantations since 1964 (Hospital in Midwest, 2015). Ranking in the
top nationally in patient outcomes as well as the number of transplants performed, this center
serves as the largest and most successful transplantation program in the midwest (Hospital in
Midwest, 2015). With over 200 kidney and 100 liver transplants performed yearly, this center
offers five satellite clinics to provide convenient and exceptional patient care while sustaining
the mission, values, and vision of the academic medical center.
There is a strong external environment within this organ transplantation center. Centers for
Medicare and Medicaid Services (CMS) and Organ Procurement and Transplant Network
(OPTN), the regulating bodies for transplant centers, receive data on all solid organ transplants
and donations from The Scientific Registry of Transplant Recipients (SRTR) (Scientific Registry
of Transplant Recipients, 2015). Transplant centers receive generated reports from SRTR every
six months.
In the summer of 2014, three reports were released at once regarding quality measures. The
center did not meet quality standards on two of the three reports in patient survival and graft
survival resulting in lack of compliance for CMS (G. McNatt, personal communication, October
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15, 2015). This resulted in a mitigating factors report to CMS as well as an overhaul within the
organization. An organizational assessment plan was developed to ensure that these citations
would be resolved.
A nephrologist at the center developed Real-time Analysis and Performance Improvement
Dashboard (RAPID) to monitor the performance of patient and graft survival (Hospital in
Midwest, 2015). With the one year lag time with SRTR, this dashboard allowed centers to
identify performances that may trigger regulatory review by United Network for Organ Sharing
(UNOS) or CMS.
The center also analyzed patient outcomes along with patient satisfaction rates. This analysis
resulted in each patient being assigned a nephrologist and nurse coordinator before their
discharge from the hospital. The nurse coordinator made weekly phone calls to the patients as
well as the patient was seen in the clinic more frequently. This intent was not only to improve
continuity of care but improve patient satisfaction.
To improve patient outcomes, the center evaluated the types of patients transplanted at the
center and decreased the age of recipients they would transplant. They also developed new
protocols to assess patients before they were listed for transplantation. This involved utilizing
the Montreal Cognitive Assessment (MoCA) and the Timed Up and Go test (TUG) to assess
patient’s cognitive status and frailty. Depending on these results, patients were either sent to a
gerontologist or physical therapy for further evaluation on cognition and frailty.
Within a year, the center noticed remarkable improvement with patient satisfaction as well as
patient outcomes. However, patients were still seen in the clinic with abnormal glucose levels
and the staff believed this was out of their scope of practice. There was concern about glycemic
control within the first 30 days post-transplantation. In August 2015, members of the transplant
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quality team reached out to the endocrinology team at the academic center requesting their
assistance on this problem.
At the Glycemic Control Committee (GCC) meeting held in August 2015, assessment data
and key stakeholders were identified. With the current health care culture at CTC, the
endocrinology team explored how many endocrinology consultations were initiated by the
transplant team with kidney and liver transplant patients. The GCC recognized that this has been
a constant issue over the years because several members of the endocrinology team as well as
transplant team have opposing views of glycemic control in post-transplant patients. Attendees
at the meeting agreed to follow up in October 2015 after gathering data to determine if there was
a need for endocrinology consultation with transplant patients.
An organizational assessment was performed as well as a SWOT analysis, illustrating
potential barriers, challenges, and threats that could cause problems for implementation of a
proposed project of improving glycemic control (See Appendix C). This organizational
assessment also assessed the current practices for glycemic control among all transplant patients.
The heart and lung transplant patients receive endocrinology consultation, whereas the kidney
and liver transplant patients on the same unit do not. The lack of standardized care among these
transplant patients has been confusing for nursing staff but has also been part of the health care
culture for over a decade. From the organizational assessment, a fishbone diagram was
developed that determined reasons for poor glycemic control (See Appendix D). As part of the
organizational assessment, information was gathered that determined that over 20% of patients
with a history of diabetes were not consulted by endocrinology (See Appendix E). Of these
patients not consulted, 51% of kidney transplant patients recorded having two or more readings
of blood glucose (BG) levels less than 60 mg/dL during their hospital stay. Whereas, 67% of

QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT

20

liver transplant patients not consulted recorded having two or more readings of blood glucose
(BG) levels greater than 200 mg/dL (See Appendix F). The organizational assessment also noted
that several of the patients transplanted had many risk factors associated with PTDM (See
Appendix G). Since glycemic control affects patient outcomes and from the information
collected during the organizational assessment, the director of CTC and the transplant surgeons
agreed that this was a concern that needed to be addressed.
Project Plan
Purpose of the Project
The purpose of this project was to address the process measures of increasing appropriate
consultations for evaluation and treatment of PTDM patients that would lead to an important
quality measure of improved glycemic control for this population. This was addressed by
answering the clinical question: Will appropriate consultations to the endocrinology team occur
in patients with abnormal glucose in the post-transplant period after initiation of a nurse driven
clinical pathway?
Objectives
Efforts to improve glycemic control in post-transplant patients was evaluated by developing a
quality improvement process that:


Created and implemented a nurse driven clinical pathway that established criteria for
endocrinology consultation in kidney and liver transplantation on May 2, 2016.



Evaluated knowledge of nursing staff after in-service and implementation of nurse driven
clinical pathway on May 2, 2016.



Analyzed data on the number of consultations that were obtained after pathway
implementation on June 7, 2016.
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Evaluated if appropriate consultations to endocrinology were initiated on June 7, 2016.

Type of Project
The project was a quality improvement (QI) initiative. QI “consists of systemic and
continuous actions that lead to measureable improvement in health care services and the health
status of targeted patient groups” (HRSA, 2011, p. 2). QI is directly linked to the delivery
approach and systems of care within an organization. To improve quality, the current system of
care requires change within an organization. This is obtained following four key principles: QI
in systems and processes, focus on patients, focus on team approach, and focus on use of data
(HRSA, 2011).
Within in this project, the systems and processes as well as the focus of a team approach was
evaluated during an organizational assessment (see Appendix C). Utilizing data that determined
poor glycemic control in this population and how patient outcomes were affected, members of
the transplant and endocrinology teams initiated actions to develop ways to improve glycemic
control.
Setting and Needed Resources
The setting for implementation of this project occurred on the cardiac transplant intensive
care unit (CTICU) and the step down floor for transplant patients at the academic medical center.
The resources needed to complete this project included physicians from transplant surgery,
endocrinology team, pharmacy, quality leaders from transplant, project coordinator from the
endocrinology service, nurse practitioners from endocrinology and transplant services, and
nurses from CTICU and the step down unit. Other resources included agreement from members
of the endocrinology service to agree upon a pathway, set time aside to educate all staff on the
implementation of this pathway, and finally after implementation was completed, utilized the
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quality teams to gather data to determine if consultations to the endocrinology service increased
and were appropriate. Other resources considered were the support from the unit managers as
well as the additional time within the current work day for staff to attend the in-service to learn
about the clinical pathway implementation.
Design for the Evidence-based Initiative
DMAIC was the conceptual model used to guide the interventions for this project (See
Appendix B) (Pande et al., 2002).


Define the problem: Patients who are diagnosed with PTDM have close to an 80%
increase in mortality from any cause and over a 45% increase in mortality from
cardiovascular disease (Cosio, Hickson, Griffin, Stegall, & Kudva, 2008). This condition
is also linked to a 24% increase risk of graft failure along with acute rejection (Cole,
Johnston, Rose, & Gill, 2008). Currently the organization does not have protocols in
place to screen patients for diabetes or process measures to improve appropriate
consultations to the endocrinology service. Increasing appropriate consultations for
evaluation and treatment of PTDM patients would lead to an important quality measure
of improved glycemic control for this population. From the organizational assessment,
there was evidence that poor glycemic control exists in this patient population.



Measure: Over 20% of patients with history of diabetes were not consulted to the
endocrinology service. Of these patients not consulted, 51% of kidney transplant patients
recorded having two or more readings of blood glucose (BG) levels less than 60 mg/dL
during their hospital stay. Whereas, 67% of liver transplant patients not consulted
recorded having two or more readings of blood glucose (BG) levels greater than 200
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mg/dL. Several of the patients transplanted had many risk factors associated with
PTDM. These risk factors are associated with poor outcomes in this patient population.


Analyze: Analyze the data from the organizational assessment. A fishbone diagram was
developed concluding that poor glycemic control in this organization was multifactorial.



Improve process performance: Utilizing evidence from the literature as well as the
information gathered from the organizational assessment, members of the endocrinology
team met to discuss quality improvements. This team worked together to develop criteria
for consulting the endocrinology service within this patient population as well as
discussed ways to implement a pathway for sustainability.



Control: Once pathway was implemented, data was measured and analyzed to determine
if the pathway improved consultations as well as determined if the consultations were
appropriate. Once information was gathered, data was disseminated to endocrinology
and transplant teams. This information can then be used to develop pathways for the
outpatient setting. Based on the current literature, over time appropriate consultations to
endocrinology will support the transition plan to primary care for improve glycemic
control in the outpatient setting.

Participants
The participants included any patient who received a kidney or liver transplant, nursing staff
caring for this population, the GMS service, and transplant quality leaders. The nursing staff was
responsible to recognize which transplant patients met criteria for consultation while the quality
leader was responsible for providing data to determine if consultation occurred.
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Measurement: Sources of Data and Tools
Data was collected by the DNP student and quality leaders one month after the pathway was
implemented. All information was protected through the academic center and data was not
replicated for outside use. The data collected was from documentation from the surgical list of
the number of patients who received a kidney and liver transplantation. Other data collected was
derived from the charts of patients who received a kidney or liver transplantation and the number
of patients meeting criteria for consultation (See Appendix L). This data was utilized to
determine the percent of appropriate consultations after pathway implementation.
Steps for Implementation of Project, including Timeline
During the implementation of the project, the DNP student (See Appendix H):


Gathered data and best practices from the literature, collected data (risk factors for
PTDM) from the organizational assessment which guided in developing the pathway.



Developed a nurse driven clinical pathway for endocrinology consultation utilizing the
data from the organization and current literature (See Appendix I).



Presented pathway to the endocrinology team for review and recommendations.



Elicited recommendations from endocrinology team and made corrections.



Obtained approval of new clinical pathway from GMS service.



Obtained clinical pathway approval from Glycemic Control Committee (GCC).



Obtained approval from nurse managers and education coordinators on CTICU and the
step down unit.



Presented clinical pathway for approval to Nursing Policy and Procedure Subcommittee
and Nursing Professional Practice Committee.
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Educated all nursing staff on CTICU and the step down unit, through several sessions of
in-service education (See Appendix I, J). Staff understanding of new pathway was
determined by a sign off sheet and post survey that stated staff understood new criteria
and clinical pathway, when implementation would occur, and their responsibilities (See
Appendix K).



Implemented clinical pathway on CTICU and the step down unit.



After one month of implementation, evaluated clinical pathway using an evaluation tool.
This tool evaluated how many patients were transplanted, how many met the criteria, and
how many were consulted appropriately (See Appendix L).



Compared before and after consultation rates by utilizing the evaluation tool (See
Appendix L).



Discussed results with the endocrinology team at the Glycemic Control Committee
(GCC) and quality meetings.



Evaluated current clinical pathway and made recommendations for further changes and
possible implementation of expanding the pathway for outpatient setting in this transplant
population.



Disseminated results of the final project at Grand Valley State University Kirkhof
College of Nursing during the final defense of the project.

Ethical and Human Subjects Protection
With the QI initiative, no contact of human subjects occurred during this project intervention.
Data was collected but protected under the protocols regarding de-identification under the
academic medical center. An application was submitted and approved through Grand Valley
State University (GVSU) Human Research Review Committee’s (HRRC) for Institutional
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Review Board (IRB) determination. The IRB found that the project was quality improvement
and not research. There was already an exempt status granted by the IRB at the academic
medical center, for a larger project that the DNP student was working on with other members at
the organization (See Appendix M).
Budget
Cost considerations for this project required human resources and time of the endocrinology
team working together to approve a clinical pathway for endocrinology consultation. Additional
resources involved the time necessary to train nursing staff on the pathway implementation as
well as the financial cost of sustainability, cost of staff in service education, and the use of
conference rooms for educational sessions. Furthermore, the cost of time from stakeholders,
managers, educators, endocrine service, transplant team, and the DNP student to review,
approve, and implement the quality improvement project was taken into consideration.
Based on the average wages of an endocrinologist, a nurse practitioner, a nurse, and a project
coordinator along with the time utilized to implement this project (in hours), a monetary value on
the time spent implementing this project was calculated (Hospital in Midwest, 2016;
Payscale.com, 2016; Salary.com, 2016). Other expenses included the education materials and
laminated documents that were placed in each patient room on CTICU and the step down unit for
project implementation. The total expenses were $3981.97 for this project implementation (See
Appendix N).
Endocrinology consultations are a surrogate measure to potentially result in improved
outcomes of glycemic control. Appropriate consultations to address glycemic control have the
potential to decrease readmissions driven by poor glycemic control which then leads to cost
savings. The readmission rates at this academic medical center within 30 days post-transplant
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range from 16% for liver transplant patients to 31% for kidney transplant patients, averaging two
patients readmitted per quarter (K. Thomas, personal communication, June 6, 2016). The
average length of stay (LOS) for these patients once they are readmitted range from 7.7 days for
liver transplants to 9.9 days for kidney transplant patients. The reasons for readmission are
potentially driven by poor glycemic control: infection, acute rejection, or hyperglycemia (K.
Thomas, personal communication, June 6, 2016).
The fixed cost for 24 hours for a patient in the CTICU is $4100.00 compared to $1889.00 on
the step down unit (Hospital in Midwest, 2016). Analyzing this data along with the LOS for
readmissions for kidney and liver transplantations, the expense of one kidney transplant patient
readmitted ranges from $18,701.00-$40,590.00. Whereas, the expense of one liver transplant
patient readmitted ranges from $14,545.30-$31,570.00 (See Appendix O). Therefore evaluating
the cost of the project implementation compared to the cost of one patient readmitted, there is a
potential savings of $14,719.03-$36,608.03 for preventing readmission in the kidney transplant
population. Whereas the potential savings for liver transplantation is $10,563.33-27,588.03 (See
Appendix P). From this data, estimated quarterly savings can range from $29,438.06-$73,216.06
for kidney transplant patients and $21,126.66-$55,176.06 for liver transplant patients. Therefore,
there is an estimated potential yearly cost savings as high as $292,864.24 for kidney transplant
patients and as high as $220,704.24 for liver transplant patients if eight readmissions per year
were prevented (See Appendix Q).
Project Outcomes
One month after project implementation, the DNP student collaborated with the transplant
quality leader and collected data on the number of kidney and liver transplantations that occurred
from May 2-May 31, 2016. Other data collected consisted of the number of patients meeting
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criteria for consultation per the new pathway, and how many appropriate endocrinology
consultations actually occurred. This data will then be disseminated to the endocrinology and
transplant team during the July quality meetings in the form of charts that list how many
transplants occurred during this time, how many transplants met criteria (percentage), and how
many patients meeting the criteria were actually consulted (percentage). Another chart will show
the comparison of appropriate consultations before and after pathway implementation. As a
result of this quality improvement project, the following outcomes were realized:


A nurse driven clinical pathway was created that established criteria for endocrinology
consultation in kidney and liver transplantation on May 2, 2016.
Outcome measure: Transplant nurse practitioners, surgical intensive care unit (SICU)
physicians, endocrinology team, transplant pharmacists, nurse managers, education
coordinators, quality teams on CTICU and the step down unit, and nursing committees
approved criteria and the clinical pathway based on current literature and organizational
needs (See Appendix I). Approval was met prior to the May 2, 2016 project
implementation.



Nursing staff knowledge was evaluated after in-service and implementation of nurse
driven clinical pathway on May 2, 2016.
Outcome measure: The majority of nursing staff (97% on CTICU and 85% on the step
down unit) completed in-service education (Appendix J) and a post survey (Appendix K).
The majority of nurses (92%) felt the clinical pathway pertained to their job, 90% stated
that they understood the purpose and criteria needed to consult the endocrinology service,
and 80% understood their responsibilities pertaining to the clinical pathway. However
only 60% of nurses felt the pathway would improve their work load, whereas, only 4%
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felt the pathway would create more work for them. Nurses felt the potential barriers that
would prevent them from consulting endocrinology were remembering to page,
weekend/night shift coverage would not be responsive, receptive, or kind; increased
glucose checks obtained by nursing, and there was a concern of pushback from the
transplant team for when nursing would place the order (See Appendix R).


Data was analyzed on the number of consultations that were obtained after pathway
implementation on June 7, 2016.
Outcome measure: Data was assessed and evaluated regarding a change in appropriate
consultation rates with the new pathway. Normally over 30 transplants occur per month.
However, in the month of implementation, 21 transplantations occurred (16 kidney and 5
liver). Of the patients consulted to endocrinology, 100% of those consultations were
appropriate. However, 19% of patients were not consulted according to the criteria of the
pathway (See Appendix S). The barriers to consultation were:
o Nurses on units failed to place order for consult (underlying reason unknown)
o Transplant team failed to place order for consult when the patient was on an
insulin drip in the operating room. The team stated they felt the order/consult was
unnecessary.
o Nurses on step down unit failed to obtained glucose checks per the guidelines of
the pathway. Hyperglycemia was noted from the labs obtained daily.



The appropriate number of consultations to the endocrinology service were evaluated on
June 7, 2016.
Outcome measure: From the data collected after a month after project implementation,
appropriate consultations occurred. Comparing the data before the pathway
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implementation to after implementation, there has been a 4% reduction in missed
consultations in kidney transplantation and a 2% reduction in missed consultations with
liver transplantations (See Appendix S). When performing the Chi-square test, there was
not statistically significant evidence (p = 0.948) to conclude that appropriate consultation
to the endocrinology service and abnormal glucose in the post-transplant period were
related (See Appendix S). However, a larger sample could have affected statistical
significance (N = 21). Even though there was not a statistically significant change in
number of consultations, there was a clinical meaningful difference because the patients
who were consulted after pathway implementation received the benefit of management
by endocrinology specialists to improve glycemic control post transplantation. Therefore
the recommendation for future study would be a longer evaluation period to determine
true significance level. Project results will be disseminated during the July quality
meetings to the transplant and endocrinology teams regarding the number of appropriate
consultations with new clinical pathway implementation to serve as a guide for a longer
implementation period of current pathway as well as possible expanded pathways to
include the outpatient setting in this transplant population.
Implications for Practice
Up to 30% of all patients with solid organ transplantation will develop PTDM (United
Networking for Organ Sharing, 2015). Since there is an inconsistent definition of PTDM, proper
identification of patients at risk of PTDM, and with utilization of the evidence from the current
literature, interventions can be implemented to improve glycemic control in a transplant center.
Utilizing the Donabedian model that guides quality improvement efforts to improve outcomes,
evidence suggests that with pathways in place to guide appropriate consultation with
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endocrinology teams, treatment to control blood sugar is initiated. The process of improved
glycemic control along with proper education and resources on the nursing units, patient
outcomes could potentially lead to improved control that results in a decreased risk of
cardiovascular morbidity, reduced graft function, and mortality (Midtvedt et al., 2011). The
recommendation is for transplant and endocrinology teams to continue to work together to
develop clinical pathways to appropriately consult endocrinology teams that is consistent with
the standardized care of other organ transplants. Though this is a small piece to a larger
problem, the use of standardized pathways will potentially improve care leading to improved
glycemic control in the kidney and liver transplant population. Early consultation immediately
after surgery will potentially improve the transitions of care from inpatient to outpatient setting
for this patient population. Further implications for determining the effects of appropriate
consultation beyond this study should be formally determined as a recommendation following
this QI intervention. Based on this project implementation, there were important
successes/difficulties encountered, project strengths, opportunities for improvement, and
sustainability factors addressed, limitations to the quality improvement project, and the period
after the project. Also a reflection of the Essentials of DNP education were utilized during this
QI intervention (American Association of Colleges of Nursing, 2006).
Successes of Project
Throughout the development and implementation of this project, several members of the
transplant team, surgical intensive care unit (SICU) team, endocrinology team, pharmacy team,
nursing, and quality team stated that there was a better working relationship and communication
among the disciplines. These disciplines worked together on a project and collaborated on
establishing a pathway for an issue that has been a topic of discussion for years with no
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resolution. A theme of empowerment emerged during the in service educational sessions where
the nurses stated they “felt they had direction on an issue and felt they could do something to
improve patient outcomes.” Nurses also felt empowered after the DNP student presented at
nursing committees and the nurses stated this project could be implemented in other departments
to improve patient outcomes. This project ultimately empowered disciplines, especially nursing,
about the importance of glycemic control in transplantation which can then be utilized in other
departments in the hospital.
Difficulties of Project
There were many difficulties to overcome with this project implementation. Many of these
difficulties were associated with the structure and processes within the organization. First of all
empowering multiple disciplines with the concept of change and the positive outcomes that can
occur when change is present was more difficult to overcome because of the organizational
barriers that occurred in this large medical center. One organizational barrier was managing
differences in opinions among transplant and endocrinology providers. Another example of an
organizational barrier was understanding the stakeholders’ level of support for quality
improvement. These stakeholders (i.e. members of the transplant team) would collaborate on the
project but then they would refuse to place orders for nurses to obtain glucose monitoring on
their patients. These same stakeholders stated they supported the pathway but would not take
responsibility for the process changes that occurred in the transplant patient population. Another
difficulty was understanding the staffing barriers and processes on the nursing units and how the
level of autonomy was different among team members on the various units. Staff on the step
down unit had a culture where the nurses are driven by tasks and they would not monitor a
glucose level despite the pathway guidelines unless an order was placed. In contrast, the CTICU
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nurses would monitor glucose levels regardless of the order status. This difference was
significant and was illustrated during the evaluation process of the project when reasons for not
monitoring glucose levels was determined by provider order status.
Strengths of Project
The strengths of the project were the collaboration of leaders and clinicians in the field of
endocrinology and transplant teams working together to improve the quality measures of
glycemic control in the transplant population. Also there was support for the clinical pathway
and project implementation from multiple disciplines including nursing committees as illustrated
by their approval at several presentations and meetings. Another strength to the project was the
DNP student has worked at the large academic center for nearly eight years and has developed
positive working relationships with multiple disciplines. These supportive relationships allowed
meetings with stakeholders to occur in a timely fashion since the meetings may not have
occurred if the DNP had not already established these professional connections. From this
networking, there was support for this project which allowed implementation of pathway that
standardized the care among all transplant patients.
Weaknesses of Project
Weaknesses in the project was lack of collaboration with all of the endocrinology team (i.e.
fellows) when creating the guidelines for the clinical pathway. This was a strategic move to
avoid potential opposition from these members. However, these same members were the
physicians taking call on nights and weekends where the nurses already felt these people would
be a barrier to endocrinology consultation. Preventing these key stakeholders from collaborating
in the development of the pathway still caused confusion and opposition once the pathway was
implemented. This avoidance could have potentially affected the sustainability of the pathway.

QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT

34

Another weakness to the project was lack of consideration of the culture of nursing regarding
clinical decision making. Nurses on the step down unit stated they did not feel comfortable
monitoring glucose levels without an order despite the guidelines of the pathway. The status of
the transplant order sets and the lack of an order to monitor glucose levels was not discussed as a
potential concern of project implementation.
Another weakness of this project was lack of consideration that the pathway may not be
appropriate for all transplant patients (i.e. readmissions). This pathway purposely had a low
threshold of criteria for endocrinology consultation. Whereas transplant patients who are
readmitted may or may not fit the same criteria as immediate post-transplant patients, causing
inappropriate consultations. Even though this project did not evaluate transplants patient who
were readmitted, this weakness could cause opposition for further pathway implementation.
As much as this was a strength, the DNP student working at the organization of
implementation also served as a weakness. There were boundaries crossed when the student was
in her working role compared to when she was in her student role. Many disciplines often
referred to this pathway as the “DNP student’s pathway” even though the pathway was approved
by nursing committees and other interdisciplinary committees. This weakness was also
compounded with the kidney and liver transplant team having opposing views of glycemic
control which often was discussed with the DNP student even during her working hours. Finally
a weakness of this project was not having the appropriate staff to manage the influx of patients
who were consulted to the endocrinology service. The management of these additional patients
were discussed but no solid plan was developed to fully handle the patient load caused from the
project.
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Limitations of Project
Limitations to this study included lack of a pre and posttest for the nursing staff as well as
limited content questions on the survey during the in-service. This occurred because there was a
lack of time for the in-service and the pretest was in a form of open discussion with the nursing
staff regarding their current knowledge of glycemic control. However for future project
implementations, a pre and posttest along with more content questions on the survey would be
encouraged. There was also a short evaluation period after implementation. The data collected
prior to implementation occurred over three months. Whereas, the evaluation period was only
one month. Additionally, the project implementation occurred during a time of low volume of
transplantations (n=21). Normally, over 30 transplantations occur each month. Therefore the
true significance of this project was not completely accurate to determine the full implications of
practice moving forward. Finally, the project only evaluated patients who were immediately
post-transplant. The implications of practice for all transplant patients on these nursing units was
not addressed in the evaluation of the pathway.
Sustainability
Prior to the project implementation, no interventions to address glycemic control posttransplant for kidney and liver patients had been trialed before at this organization. For years,
glycemic control improvement among transplant patients has been a topic of discussion with no
resolution. In the past, members of both endocrinology and transplant teams had opposing views
of glycemic control, resulting in no previous pathway implementation. Therefore, strategic
pathway revisions are key to stakeholder support and sustainability. With transplantation highly
regulated, these interventions will not only affect patient outcomes and improve patient safety;
but could improve the centers approval status with Centers for Medicare and Medicaid Services
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(CMS) by improving transplantation outcomes (Centers for Medicare & Medicaid Services,
2015). Moving forward, recommendations for clinical pathway sustainability consist of:


Evaluating the pathway after three months or until there is a sample size greater than 30.
The current evaluation period was too short with a small sample size (n=21) to provide
data to show statistical significance for or against the pathway.



Re-evaluating the pathway criteria that would initiate consultation. This evaluation
would determine if the criteria encompasses all of the transplant population, not just
immediate post-transplant patients as well as determine if the pathway’s criteria threshold
is too low for all of the transplant patients.



Designating a member from the GCC team to take over the pathway implementation after
the DNP student has completed the project to continue the quality process improvement
measures that the revisions of the pathway would allow.



Working with quality leaders to have glucose monitoring part of the transplant order sets.
A weakness in this study was determining that nurses were not monitoring glucose levels
because there was not an order placed. For project sustainability, establishing glucose
monitoring in the order sets may encourage nurses to be compliant with the pathway
guidelines.



Empowering the transplant team to have accountability for the glycemic control of their
patient population. The current culture at this center focuses more on immediate
transplantation outcomes instead of long term glycemic control in this patient population.



Establishing a business plan to monitor and evaluate the current staff who would manage
the influx of patients who are consulted to endocrinology. This project study illustrated
an influx of patients for the endocrinology service that over time could be difficult to
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manage with their current staff. This business plan would include the use of full time
employees to manage the pathway, triage acute needs for this patient population, allocate
resources, and provide clinical decision support.


Considering the cost of a future project implementation and potential cost savings of the
QI improvement project. Including the cost considerations, there is an estimated
potential yearly cost savings as high as $292,864.24 for kidney transplant patients and as
high as $220,704.24 for liver transplant patients if glycemic control could be improved.

Essentials of DNP Education
The DNP prepared nurse strived to delineate the doctor of nursing practice (DNP) Essential
competencies along with theory to guide practice during this project implementation (American
Association of Colleges of Nursing, 2006). These competencies, served as a foundation,
provided the leadership principles that ensured quality improvement in the organization, and
analyzed clinical scholarship to implement evidence based practice. Several of the DNP
essentials were utilized during this project.
Essential I: Scientific Underpinning for Practice. This Essential provides the scientific
basis necessary for advanced nursing practice (AACN, 2006). This Essential was enacted by the
DNP student obtaining an extensive organizational assessment and literature review for this
quality improvement project. This Essential was delineated in the frequent meetings with the
mentor and members of endocrinology at the organization, in the evaluation of the pathway and
in making changes based on knowledge from other disciplines before project implementation.
Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking. This Essential describes the preparation needed in the organizational and
systems leadership that affects the delivery in health care and patient outcomes (AACN, 2006).
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This Essential was delineated in this project by the DNP student working and collaborating with
the transplant quality leader on the process improvement measures, dashboards, and metrics used
at the transplant center. The DNP student also attended several kidney and liver quality
meetings, shadowed the medical quality leader, and incorporated the existing DMAIC QI
framework of the organization to improve successful implementation.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice.
Essential III describes the evaluation, integration, translation, and application of evidence-based
practices (AACN, 2006). The competency for this Essential was met with the implementation
and evaluation of the QI project. The utilization of evidence based practices guided the
implementation to analyze, predict, and disseminate findings to improve healthcare outcomes.
The DNP student also collaborated with quality leaders, project coordinators, and multiple
disciplines in identifying the gaps in evidence based practice at this organization.
Essential VI: Interprofessional Collaboration for Improving Patient and Population
Health Outcomes. This Essential concentrates on the importance of expanding
interprofessional collaboration, ensuring that the DNP student will develop the expertise needed
to assume leadership roles as well as participate in the work environment alongside collaborating
teams (AACN, 2006). This Essential was met by the DNP student providing effective
communication and collaboration developing the pathway with the mentor and members of the
endocrinology team. The Essential was also delineated with one on one meetings with key
stakeholders (i.e. SICU team, members of transplant team), the DNP student’s presentation of
pathway to the step down unit’s quality meetings, nursing committees, and transplant pharmacy
staff meetings. The DNP student also performed educational in-services to over a 100 nurses, as
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well as, collaborated with nurses, pharmacy, transplant, and endocrinology teams to discuss
solutions to potential barriers of project implementation.
Essential VIII: Advanced Nursing Practice. This Essential describes the clinical
specialization content of the advanced nursing practice through the development of therapeutic
relationships with patients and providers, utilization of advanced clinical decision making, and
mentoring others in the nursing profession (AACN, 2006). This Essential was delineated in this
project by the DNP student presenting at the organization’s outcomes research collaborative
meeting with the discussion consisting of the enactment of the DNP as well as the clinical
pathway implementation. The DNP student also guided and mentored nurses on the project
implementation as well as developed and sustained therapeutic relationships with multiple
disciplinary teams for optimal patient outcomes.
Dissemination of Outcomes
Dissemination of results will first occur with the stakeholders at the organization where
project implementation occurred. The DNP student will present at the July, 2016 quality
meetings. The final presentation will be to the DNP student’s committee at the scholarly project
defense. Final project results will be disseminated in the future at the organization’s research
committees, in future poster presentations at conferences, and possible journal publications.
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Appendices
Appendix A: The Donabedian Model

Figure A. The Donabedian Model. Reprinted from “Evaluating the quality of medical care,” by A. Donabedian,
1966, Milbank Memorial Fund Quarterly, 44, p. 166-206. Copyright 2004 by jasn.asnjournals.org. Reprinted with
permission.
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Appendix B: The Define Measure Analyze Improve Control (DMAIC) Process

Figure B. DMAIC Model. Reprinted from Villanova University by University Alliance, 2016, Retrieved from
http://www.villanovau.com/resources/six-sigma/six-sigma-methodology-dmaic/#. VxL7XvkrLX4. Copyright 2016
by University Alliance. Reprinted with permission.
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Appendix C: SWOT Analysis for Academic Medical Center



















Strengths
Leading hospital in Midwest for education,
research, and patient care
Magnet certified
Transplant center serves as the largest and
most successful transplantation program in
Illinois
Transplant center ranked top nationally in
patient outcomes and transplant performed
Over 200 kidney transplants yearly
Over 100 liver transplants yearly
Several satellite clinics
Developed Real-time Analysis and
Performance Improvement Dashboard
(RAPID) for quality improvement
Committed to our patients
Strong leadership
Weaknesses
Lack of communication among staff members
High turnover rates among staff
Divided health care culture
Divided viewpoints among surgeons
Poor follow up with patients
Overbooked clinic days
Poor patient satisfaction
Poor discharge teaching
















Opportunities
Improve wait times for organ transplantation
Change in allocation system for organ
transplantation
Heavy regulation to ensure safe and effect
transplant system
No change in reimbursement with Affordable
Care Act
United Network for Organ Sharing (UNOS)
has changed criteria for who is listed
RAPID software to improve quality assurance
Improve patient satisfaction with improved
discharge planning
Improve patient follow up with appropriate
consultations

Threats
Changing electronic health record systems
Possible probationary period from regulating
bodies from poor patient outcomes from
Scientific Registry of Transplant Recipients
(SRTR) reports
Complete closure of transplant program
Government regulations
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Appendix D: Fishbone diagram of Poor Glycemic Control
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Appendix E: Non-Glucose Management Service Consults and Status
11/1/2014-2/28/2015
Patients
Kidney
Liver

43
18

Patients with History of
DM (%)
10 (23%)
4 (22%)
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Appendix F: Non-Glucose Management Service Consults and Glucose Outcomes
11/1/2014-2/28/2015
Patients
Kidney
Liver
Total

43
18
61

≥2 BG values
<60 mgdl
22 (51%)
0
22

≥2 BG values
BG>200mgdl
5 (11%)
12 (67%)
17

Both Hypo
and Hyper
7
3
10
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Appendix G: Kidney Transplantations with Risk Factors
11/1/2014-2/28/2015

Kidney

Total
Age>45
Transplants
61
36 (60%)

BMI>25
kg/m²
30 (49%)

History
of DM
27 (44%)

African
American/Hispanic
23 (38%)

Hyperglycemia
BG>140
20 (33%)
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Appendix H: Implementation of Project Timeline
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Appendix I: Criteria for Nurse Driven Diabetes Clinical Pathway in Kidney/ Liver
Transplantation
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Appendix I: Abbreviations Key for Clinical Pathway
GMS = Glucose Management Service
gtt = drip
Q = every
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Appendix J: Education Materials
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Appendix K: Nurse Driven Clinical Pathway Survey
Nurse Driven Clinical Pathway Survey
For each of the statements below, circle the response that best characterizes how you feel about
the statement, where 1= Strongly Disagree, 2=Disagree, 3=Neutral, 4=Agree, and 5=Strongly
Agree

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

The in-service pertains to my job

1

2

3

4

5

I understand the purpose and criteria
needed to consult endocrinology

1

2

3

4

5

I understand my responsibilities
pertaining to the clinical pathway

1

2

3

4

5

I feel the clinical pathway will
improve my work load

1

2

3

4

5

I feel the clinical pathway will cause
more work for me

1

2

3

4

5

Please list potential barriers that would prevent you from consulting endocrinology?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
_____________________________________________________________________________
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Appendix L: Evaluation Tools
Hx
Hyperglycemia Hypoglycemia Insulin Supplemental Was Pt
Did pt
TX of
Barriers to
2X>140 or
1X<60 or
gtt
Insulin
consulted meet
# DM
consultation
1X >250
2X<70
Y or N
Y or N
Y or N criteria
1
2
3
4
5
6
7
8
9
10

Total Transplants

Total Consulted
Appropriately (%)

Should have been Consulted
(%)

Type of Transplant

Consults Missed before
Pathway Implementation
(%)

Consults Missed after
Pathway Implementation
(%)

Kidney
Liver
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Appendix M: IRB Letters

58

QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT

59

QUALITY IMPROVEMENT INITIATIVE IN TRANSPLANT

60

Appendix N: Expense Report for Project Implementation
Expenses
2 Endocrinologists

1 Project Coordinator

1 Nurse Practitioner

Average Salary/Wage
$101.00 per hour
($211,000 per year based
on 40 hour work week)
$21.90 per hour
($45,560 per year based
on 40 hour work week)
$50.20 per hour
($104,379 per year based
on 40 hour work week)

Hours (Time in
meetings/education)

Total
Cost

5

$1,010.00

5

$109.50

5

$250.00

DNP Student

$40.00 per hour

30

$1200.00

106 Nurses

$40.00 per hour

26.5

$1,060.00

Education Materials/
Laminated Documents

$352.47

Total

$3,981.97
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Appendix O: Readmission Expenses for one Kidney and Liver Transplant Patient
Readmission Expenses for a Kidney Transplant Patient
Unit
CTICU
Step Down Unit

Fixed Room Rate
for 24 hours ($)
$4100.00
$1889.00

Average Length of
Stay (LOS)
9.9
9.9

Total
$40,590.00
$18,701.10

Readmission Expenses for a Liver Transplant Patient
Unit
CTICU
Step Down Unit

Fixed Room Rate
for 24 hours ($)
$4100.00
$1889.00

Average Length of
Stay (LOS)
7.7
7.7

Total
$31,570.00
$14,545.30
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Appendix P: Cost Savings for Kidney and Liver Transplantation
Cost Savings for Kidney Transplantation
Readmission
Expenses
(one Patient)
Project
Implementation
Expenses
Total Cost Savings

CTICU

Step Down Unit

$40,590.00

$18,701.00

$3,981.97

$3,981.97

$36,608.03

$14,719.03

Cost Savings for Liver Transplantation
Readmission
Expenses
(one Patient)
Project
Implementation
Expenses
Total Cost Savings

CTICU

Step Down Unit

$31,570.00

$14,545.30

$3,981.97

$3,981.97

$27,588.03

$10,563.33
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Appendix Q: Estimated Quarterly and Yearly Cost Savings for Kidney and Liver
Transplantation
Estimated Cost Savings for Kidney Transplantation

CTICU
Step Down Unit

Quarterly
(based on 2
readmissions per
quarter)
$73,216.06
$29,438.06

Yearly
$292,864.24
$117,752.24

Estimated Cost Savings for Liver Transplantation

CTICU
Step Down Unit

Quarterly
(based on 2
readmissions per
quarter)
$55,176.06
$21,126.66

Yearly
$220,704.24
$84,506.64
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Appendix R: Nurse Driven Clinical Pathway Survey Results

Nurse Driven Clinical Pathway Survey
Strongly Disagree

The in-service pertains
to my job

I understand the purpose
and criteria needed to
consult endocrinology

8%

I feel the clinical pathway
4%
will improve my work load

Neutral

Agree

Strongly Agree

92%

10%

I understand my
responsibilities pertaining
to the clinical pathway

I feel the clinical pathway
will cause more work for me

Disagree

90%

20%

14%

80%

22%

53%

60%

11%

29%

Please list potential barriers that would prevent you from consulting endocrinology?





Remembering to page Endocrinology
Weekend/night shift coverage not responsive, receptive, or kind
More frequent glucose checks obtained by nursing
Concern of pushback from transplant team for placing order

3%4%
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Appendix S: Evaluation of Project

TX #

1
DD
Kidney

Hx
of
DM
No

Hyperglycemia
2X>140 or
1X >250

Hypoglycemia
1X<60 or
2X<70

Insulin
gtt
Y or N

Supplemental
Insulin
Y or N

Was Pt
consulted
Y or N

Did pt
meet
criteria

Yes

No

No

No

Yes

Yes

2
DD
Kidney

3
DD
Kidney

4
LD
Kidney

5
DD
Kidney

6
DD
Kidney

7
LD
Kidney

8
LD
Kidney

9
DD
Kidney

10
LD
Kidney

11
DD
Kidney

No

Yes

No

Yes

No

No

Yes

No

Yes

No

No

No

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

No

Yes

No

No

Yes

Yes

Yes

No

Yes

No

No

No

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

No

Yes

No

No

Yes

Yes

Yes

No

Yes

No

Yes

No

Yes

Yes

No

Yes

No

No

No

Yes

Yes

Yes

Yes

No

No

Yes

Yes

Yes

12
LD
Kidney

13
LD
Kidney

14
DD
Kidney

No

Yes

No

No

No

No

Yes

No

Yes

No

No

Yes

Yes

Yes

Yes

Yes

No

Yes

No

Yes

Yes

Barriers to
consultation

Tx team failed
to place order
for consult.
Patient was on
Insulin gtt in
the OR.

Nurses on step
down unit failed
to check
glucose levels
per guidelines
of pathway
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15
DD
Kidney

16
LD
Kidney

17
LD
Liver

18
DD
Liver

19
DD
Liver

20
DD
Liver

21
DD
Liver

No

Yes

No

Yes

No

Yes

Yes

No

Yes

No

No

Yes

No

Yes

No

Yes

No

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

No

Yes

Yes

No

Yes

No

Yes

Yes

Yes

Yes

No

Yes

No

Yes

No

No

Yes

Yes

Yes

No

Yes

Yes

Yes

Yes

Nurses failed to
place order for
consult

Nurses failed to
place order for
consult

Total Transplants

Total Consulted
Appropriately (%)

Should have been Consulted
(%)
19% (N= 3)
(19% Kidney, 20% Liver)

21 transplants
(16 Kidney, 5 Liver)

100%

Type of Transplant

Consults Missed before
Pathway Implementation
(%)

Consults Missed after
Pathway Implementation
(%)

Kidney

23% (N=10)

19% (N=3)

Liver

22% (N=4)

20% (N=1)

Chi-Square Test for Significance of Appropriate Consultation to Endocrinology and
Abnormal Glucose for Post-Transplantation
Observed Values
Kidney Transplants
Liver Transplants
Total

Expected Values
Yes
13
4
17

No
3
1
4

Total
16
5
21

p- value = 0.948 (p<0.05 shows significance)

Kidney Transplants
Liver Transplants
Total

Yes
12.95
4.05
17

No
3.05
0.95
4

Total
16
5
21

